Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Granulomatosis With Polyangiitis: full-pipeline trial registry
1 of 5 indexed Granulomatosis With Polyangiitis trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Granulomatosis With Polyangiitis: 5 US clinical trials tracked, 1 recruiting.
Granulomatosis With Polyangiitis is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of South Florida, running 2 of these trials.
Enrollment posture brief
Registry condition granulomatosis-with-polyangiitis
OPEN 1 | RECR 20% | LATE 2 | EARLY 2 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Granulomatosis With Polyangiitis lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Granulomatosis With Polyangiitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Granulomatosis With Polyangiitis is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Granulomatosis With Polyangiitis research.
University of South Florida accounts for 2 of 5 trials (40%). 3 distinct sponsors appear on at least one study for this condition label.
-
Most Granulomatosis With Polyangiitis trials plan to enrol fewer than 100 people.
Median target enrolment is 30 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.
-
Granulomatosis With Polyangiitis research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
IRIS Research and Development
NCT06581562
The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
University of South Florida
NCT01933724
TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
University of Pennsylvania
NCT03919435
Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
University of Pennsylvania
NCT00315393
Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
University of South Florida
NCT02108860
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Granulomatosis With Polyangiitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Granulomatosis With Polyangiitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Granulomatosis With Polyangiitis page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Granulomatosis With Polyangiitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of South Florida sponsors the most Granulomatosis With Polyangiitis trials on record, review their full trial history before evaluating a specific study. See University of South Florida's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Granulomatosis With Polyangiitis condition card totals 5 registered trials; most-linked intervention 0 mg prednisone; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.